ProShare Advisors
GTHX

ProShare Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

ProShare Advisors’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,849
Closed -$90K – 2185
2022
Q1 		$90K Sell
11,849
-2,798
-19% -$26.5K ﹤0.01% 2055
2021
Q4 		$149K Buy
14,647
+577
+4% +$7.35K ﹤0.01% 2129
2021
Q3 		$189K Sell
14,070
-3,660
-21% -$59.6K ﹤0.01% 1806
2021
Q2 		$389K Buy
17,730
+2,820
+19% +$62.6K ﹤0.01% 1714
2021
Q1 		$359K Buy
14,910
+1,485
+11% +$34.5K ﹤0.01% 1686
2020
Q4 		$242K Buy
13,425
+3,116
+30% +$46.6K ﹤0.01% 1751
2020
Q3 		$119K Sell
10,309
-359
-3% -$5.93K ﹤0.01% 1510
2020
Q2 		$259K Buy
+10,668
New +$176K ﹤0.01% 1311
2020
Q1 		– Sell
-12,714
Closed -$336K – 1647
2019
Q4 		$336K Sell
12,714
-1,297
-9% -$30.3K ﹤0.01% 1274
2019
Q3 		$319K Buy
14,011
+620
+5% +$19.5K ﹤0.01% 1193
2019
Q2 		$411K Sell
13,391
-1,840
-12% -$38.7K ﹤0.01% 1096
2019
Q1 		$253K Buy
15,231
+228
+2% +$4.33K ﹤0.01% 1343
2018
Q4 		$287K Sell
15,003
-1,168
-7% -$43.7K ﹤0.01% 1184
2018
Q3 		$846K Sell
16,171
-260
-2% -$14.2K 0.01% 896
2018
Q2 		$714K Buy
16,431
+1,554
+10% +$66.6K ﹤0.01% 965
2018
Q1 		$551K Sell
14,877
-1,561
-9% -$41.7K ﹤0.01% 1060
2017
Q4 		$326K Buy
+16,438
New +$353K ﹤0.01% 1341

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ProShare Advisors's GTHX Position: Q2 2022 in Review

ProShare Advisors sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2022, closing a stake of 11,849 shares — an estimated $90K sold.

ProShare Advisors first reported a position in GTHX in Q4 2017 and held it in 17 quarters. The position peaked at $846K in Q3 2018. 98 funds tracked by Wall St. Rank hold GTHX as of Q2 2022.

  • ProShare Advisors reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • ProShare Advisors sold 11,849 G1 Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $90K.
  • ProShare Advisors first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2017 and held it in 17 quarters.
  • ProShare Advisors's G1 Therapeutics, Inc. Common Stock position peaked at $846K in Q3 2018.
  • 98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.